Stroke Treatment Market Size, Share, Trends, Growth, Consumption, Production, Revenue and Forecast 2020 - 2027

The global stroke treatment market is expected to grow at a CAGR of 7.1% over the period between 2020 and 2027. Furthermore, the total volume of the stroke treatment market is expected to touch new heights, rising from a value of US$ 8.2 Bn in 2019. The presence of a well-performing healthcare sector across key regional pockets has aided market growth.

The demand within the global stroke treatment market is rising in lieu of advancements in the healthcare industry. Occurrence of strokes can be severely damaging for the masses, and this factor has played an integral role in driving market demand. The healthcare industry is making earnest efforts to deal with the rising incidence of spinal and nerve disorders. Furthermore, development of supreme technologies to offer immediate aid for patients hit by strokes is a key consideration from the perspective of market growth.

The next decade is expected to herald an era of palpable growth within the global stroke treatment market. Approval of several research projects, meant to develop improved healthcare practices for stroke treatment, is behind the aforementioned projection. Healthcare centers consist of dedicated emergency wards and outpatient service departments that can deal with patients hit by an abrupt stroke. Besides, training of medical staff for emergency services follows a rigorous route involving multiple steps. Owing to the factors mentioned above, the global stroke treatment market is slated to accumulate large-scale revenues in the years to follow.

Development of New Classes to Aid Market Growth

Treatment of stroke largely depends on the quality of medical aid availability across healthcare centers and hospitals. Therefore, development of improved drugs has generated humongous revenues within the global stroke treatment market. Online marketing has played a critical role in the growth of the global stroke treatment market. On one end, it has popularised common practices for first-aid in case of a stroke; it has also led to cases of contempt on other instances. Pharmaceutical companies are focusing on generating awareness about ways of preventing strokes, and the possible treatments available to the masses. Therefore, the stroke treatment market is undergoing a phase of rapid growth and development.

Availability of Intravenous Treatments

The development of minimally invasive techniques for administering stroke treatment drugs is undoubtedly a key driver of demand. However, intravenous procedures are still used across a wide range of facilities to treat and control strokes. An AI-based software developed at the Budapest University Hospital improves the prospects of stroke treatment. The Brainomix AI software has emerged as a key development pertaining to the global stroke treatment market.

Lucrative Opportunities in U.S. Catalyze Market Growth

Healthcare companies in the stroke treatment market should increase their focus on drug development in the U.S. Favorable guidelines by health commissions and the well-established healthcare infrastructure of the U.S. are gaining the worldwide attention of stakeholders in the stroke treatment market.

Overall, North America is anticipated to maintain its lead in terms of market share and revenue during the forecast period, with a projected value of ~US$ 6.9 billion by 2027, in the stroke treatment market. Developments in the North American healthcare landscape are creating a ripple effect in the stroke treatment landscape of the U.S.

The introduction of new guidelines by health commissions in the U.S. involves speeding up the procedure of providing thrombolytic therapy to patients suffering from acute ischemic stroke. These guidelines are increasing the convenience of patients, and healthcare providers are gaining credibility in the global stroke treatment market scenario. Healthcare providers in the U.S are aiming to increase speed targets every year. Also, patients are being provided intravenous tissue plasminogen activator (tPA) drugs within minutes of their hospital arrival.

tPA Drugs Reduce Ischemia Injuries and Improve Neuroplasticity

Tissue plasminogen activator (tPA) drugs accounted for the highest revenue in 2018, with a global value of US$ 3.6 billion in the stroke treatment market. Healthcare companies gain monopoly through the sales of tPA drugs, as these are the only therapeutic agents meant to treat patients with acute ischemic stroke that have been approved by health commissions across nations. However, delayed administration of tPA drugs in acute ischemic stroke patients can lead to health complications such as intracranial hemorrhage (ICH), hemorrhagic transformation (HT), and mortality. To overcome this challenge, companies are educating healthcare professionals regarding the administration of tPA drugs within 4.5 hours of a stroke onset. Also, manufacturers are developing new drug agents with improved formulations that help reduce the incidence of ischemia injuries in case of delayed tPA administration.

As such, healthcare companies in the stroke treatment market are increasing the availability of recombinant tissue plasminogen activators (rt-PA) to ease the health complications of acute ischemic stroke patients with their thrombolytic action. Positive clinical trials have compelled healthcare providers to prescribe rt-PA drugs in order to improve neuroplasticity in stroke patients.

Key Segments

• In terms of type, the global stroke treatment market has been classified into ischemic stroke and hemorrhagic stroke. The ischemic stroke segment held a major share of the market in 2019, and the trend is anticipated to continue during the forecast period.
• Based on drug class, the global market has been segmented into tissue plasminogen activators (tPA), anticoagulants, antiplatelets, anticonvulsants, and others. The tissue plasminogen activators (tPA) segment accounted for a majority of the market share in 2019.
• In terms of distribution channel, the global stroke treatment market has been categorized into hospital pharmacies, retail pharmacies, and online pharmacies. The hospital pharmacies segment held a major share of the global market in 2018, and this trend is expected to continue of the period of forecast.
• The market value and forecasts for each of these segments have been provided from 2016 to 2027. The CAGRs of respective segments have also been provided from 2020 to 2027, considering 2020 as the base year.

Regional Outlook

• In terms of region, the global stroke treatment market has been segmented into North America, Europe, Latin America, Asia Pacific, and Middle East & Africa. North America is projected to account for a leading share of the global market during the forecast period, owing to increase in the number of patients suffering from stroke.
• For instance, according to the American Stroke Foundation, around 795,000 people experience a new or recurrent stroke each year in the U.S., which is anticipated to boost the stroke treatment market.
• Favorable funding by governments and charitable trusts for stroke research, prevention, and treatment in the country is likely to drive the market in North America.
• The stroke treatment market in Asia Pacific is projected to grow at a rapid pace in the next few years. India and China are anticipated to be lucrative markets for stroke treatment during the forecast period, owing to the high prevalence of cerebrovascular diseases, unhealthy lifestyle choices such as smoking, poor diets, and high incidence of diabetes and hypertension, which fuel the risk of developing a stroke.

Major companies profiled in the global market report are

• Bristol-Myers Squibb Company,
• Sanofi,
• Johnson & Johnson Services, Inc.
• Boehringer Ingelheim GmbH
• F. Hoffmann-La Roche (Genentech)
• Daiichi Sankyo Company, Limited 
• Amgen Inc., AstraZeneca
• Biogen Inc.

Market Segmentation

Type
Ischemic Stroke
Hemorrhagic Stroke

Drug Class
Tissue Plasminogen Activators (tPA)
Anticoagulants
Antiplatelets
Anticonvulsants
Others

Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Region
North America
Europe
Asia Pacific
Latin America
Middle East & Africa

The report has been prepared after extensive research. Primary research involves bulk of the research efforts, wherein, analysts carried out interviews with industry leaders and opinion makers. Extensive secondary research involves referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global stroke treatment market.

Secondary research also includes Internet sources, statistical data from government agencies, websites, and trade associations. Analysts have also employed a combination of the top-down and bottom-up approach to study various phenomena in the global stroke treatment market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Furthermore, the report sheds light on the changing competitive dynamics in the global stroke therapy market. These indices serve as valuable tools for existing market players as well as for entities interested in participating in the global market. The next section of the global stroke treatment report highlights the USPs, which include key industry developments in the global market, pipeline analysis, and epidemiology analysis of stroke.

The report delves into the competitive landscape of the global stroke treatment market. Key players operating in the global market have been identified, and each one of them has been profiled for their distinguishing business attributes. Company overviews, financial standings, recent developments, and SWOT are some of the attributes of players profiled in the global market report.

Key Questions Answered in Global Stroke Treatment Market Report

• What are the major drivers, restraints, and opportunities in the market?
• What are the revenue share projections of key segments of the global market for the forecast period?
• Which segment is likely to lead the market in terms of revenue by 2027?
• How are alliances & partnerships among players widening the scope for stroke treatment?
• What is the market position of different companies operating in the global market?

Research Objectives and Research Approach

The comprehensive report on the global stroke treatment market begins with an overview of the said market, followed by the scope and objectives of this study. Following this, the report provides detailed explanation of the objectives behind this study, and healthcare compliances laid down by accredited agencies in the purview of research in the global market. It is followed by the market introduction, market dynamics, and an overview of the global market, which includes VRR’s analysis of the market drivers, restraints, and trends affecting the growth of the global market. Furthermore, Y-o-Y analysis with elaborate insights have been provided to understand the Y-o-Y trends in the market. The next section of the report highlights the USPs, which include the epidemiology analysis of stroke, pipeline analysis for stroke treatment, and key industry developments in the global market.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section further divided into small sections. The entire report comprises an exhaustive collection of graphs and tables that are appropriately interspersed in the entire compilation. Pictorial representation of actual and projected values of key segments is visually appealing to the readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.